KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea
· Delayed Price · Currency is KRW 2,585.00
-170.00 (-6.17%)
At close: Apr 13, 2026
KMPHARMACEUTICAL Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 14,418 | 15,003 | 19,103 | 27,274 | 44,340 | 62,049 | Upgrade
|
| Market Cap Growth | -4.26% | -21.46% | -29.96% | -38.49% | -28.54% | -23.67% | Upgrade
|
| Enterprise Value | 29,867 | 30,160 | 32,128 | 39,519 | 56,196 | 64,798 | Upgrade
|
| Last Close Price | 2585.00 | 2690.00 | 3425.00 | 4890.00 | 7950.00 | 11125.00 | Upgrade
|
| PS Ratio | 0.90 | 0.94 | 1.32 | 1.54 | 2.84 | 2.73 | Upgrade
|
| PB Ratio | 0.51 | 0.53 | 0.59 | 0.77 | 1.22 | 1.56 | Upgrade
|
| P/TBV Ratio | 0.51 | 0.53 | 0.59 | 0.77 | 1.22 | 1.56 | Upgrade
|
| P/FCF Ratio | - | - | - | 20.45 | - | - | Upgrade
|
| P/OCF Ratio | - | - | - | 18.86 | - | 27.37 | Upgrade
|
| EV/Sales Ratio | 1.87 | 1.89 | 2.22 | 2.22 | 3.60 | 2.85 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 154.53 | - | 28.07 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 74.81 | Upgrade
|
| EV/FCF Ratio | -14.87 | - | - | 29.64 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.56 | 0.56 | 0.43 | 0.35 | 0.37 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 48.67 | - | 4.19 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 9.34 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.55 | 0.55 | 0.41 | 0.32 | 0.35 | 0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.08 | -6.08 | -5.30 | 44.67 | -5.60 | 3.03 | Upgrade
|
| Net Debt / FCF Ratio | -7.69 | -7.69 | -5.55 | 8.57 | -83.90 | -71.33 | Upgrade
|
| Asset Turnover | 0.34 | 0.34 | 0.29 | 0.35 | 0.30 | 0.44 | Upgrade
|
| Inventory Turnover | 5.47 | 5.47 | 4.52 | 5.32 | 4.76 | 5.80 | Upgrade
|
| Quick Ratio | 0.13 | 0.13 | 0.23 | 0.28 | 0.23 | 0.86 | Upgrade
|
| Current Ratio | 0.32 | 0.32 | 0.51 | 0.50 | 0.51 | 1.32 | Upgrade
|
| Return on Equity (ROE) | -13.04% | -13.04% | -13.43% | -3.68% | -10.30% | -1.52% | Upgrade
|
| Return on Assets (ROA) | -4.66% | -4.66% | -4.83% | -1.37% | -4.47% | 1.05% | Upgrade
|
| Return on Invested Capital (ROIC) | -8.01% | -7.92% | -8.29% | -2.32% | -7.76% | 1.94% | Upgrade
|
| Return on Capital Employed (ROCE) | -10.30% | -10.30% | -9.70% | -2.90% | -9.60% | 1.90% | Upgrade
|
| Earnings Yield | -27.52% | -26.45% | -23.94% | -4.84% | -8.85% | -0.98% | Upgrade
|
| FCF Yield | -13.93% | -13.39% | -12.57% | 4.89% | -0.34% | -0.16% | Upgrade
|
| Buyback Yield / Dilution | -0.21% | -0.21% | 0.00% | -0.18% | -0.20% | -29.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.